NGHIÊN CỨU TÌNH HÌNH SỬ DỤNG THUỐC ĐIỀU TRỊ TĂNG HUYẾT ÁP TRÊN BỆNH NHÂN SUY THẬN MẠN ĐANG LỌC MÁU ĐỊNH KỲ BẰNG THẬN NHÂN TẠO TẠI TRUNG TÂM Y TẾ THỊ XÃ GIÁ RAI NĂM 2021 – 2022

Abstract

Background: Chronic kidney disease (CKD) is a global health problem, especially End-Stage Renal Disease, leading to hemodialysis and increasing the risk of cardiovascular disease and mortality. Hypertension in patient with CKD is difficult to treat. Treatment of hypertension on patient with CKD requires continuously, prolongedly and closely monitoring. In hypertensive patients with CKD, antihypertensive drugs have been played an important role in controlling blood pressure, delaying disease progression, and reducing cardiovascular events. Objective: To determine the rate of using antihypertensive drugs in patients undergoing hemodialysis at Gia Rai Town Health Center in 2021-2022. Object and method method: cross-sectional descriptive study. Research on all medical records of CKD patients with hypertension, regular Hemodialysis at Gia Rai Town Medical Center from January 01, 2021 to April 30, 2022. Result: The calcium channel blocker group was the most with the rate using of 98.5%, followed by the adrenergic antagonists and ACE inhibitor groups with 93.3%. Most of the drugs using were combination, with the highest rate of 3 drugs being 87.05%. The overall appropriate rate in this study was 67.63%. Conclusion: Drug combination is necessary to effectively control blood pressure in patient with ESRD. Priority is antihypertensive drugs which reduce proteinuria and decrease cardiovascular risks.